heart transplant

SynCardia's heart beats for Wall Street, filed for IPO – updated

Tucson-based SynCardia Systems, a total artificial heart development, manufacturing and commercializing company, filed for IPO under the proposed symbol TAHT (total artificial heart temporary) and looking to raise $34.5 million according to NASDAQ. The company plans to issue 2.5 million shares with an over allotment option of $375,000 at $10-12 per share. The lead underwriter is Roth Capital … Read more

Toaster size artificial heart system bridges transplant gap- video

SynCardia Systems, a privately-held owner and manufacturer of the world’s first and only FDA, Health Canada and CE approved Total Artificial Heart, is helping patients of all generations transition as they await a heart transplant. Their device is used as a bridge for heart transplant for people suffering from end-stage biventricular heart failure in which both … Read more